Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Myelodysplastic Syndromes 48Multiple Myeloma 38Lymphoma 37Leukemia 35Lymphoma, Non-Hodgkin 29Leukemia, Lymphocytic, Chronic, B-Cell 24Hodgkin Disease 24Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Hematologic Neoplasms 18Lymphoma, Large B-Cell, Diffuse 16Primary Myelofibrosis 11Neuroblastoma 11Leukemia, Myelomonocytic, Chronic 11Neoplasms, Plasma Cell 10Myeloproliferative Disorders 10Graft vs Host Disease 10Lymphoma, Follicular 9Leukemia, Biphenotypic, Acute 9Burkitt Lymphoma 8Neoplasms 7Lymphoma, Mantle-Cell 7Leukemia, Myelomonocytic, Juvenile 7Breast Neoplasms 6Rhabdoid Tumor 5Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, T-Cell 5Lymphoma, B-Cell, Marginal Zone 5

Interventions

Melphalan 4fludarabine 3fludarabine phosphate 2Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Cyclophosphamide 2Busulfan 2Alemtuzumab 2venetoclax 1spartalizumab 1sabatolimab 1ruxolitinib 1lintuzumab 1filanesib 1Stem Cell Transplantation 1Sertraline 1Sampling Studies 1Metformin 1Lenalidomide 1Decitabine 1Clofarabine 1CPI-0610 1Bone Marrow Transplantation 1Biopsy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Preleukemia × Stem Cell Transplantation × Clear all
NCT00943592 2014-02-27

Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies

University of Chicago

Phase 1/2 Completed
82 enrolled 12 charts
Other hematologic neoplasm

Leukemia, Preleukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡